News

BioPharma Dive11h
With Verona deal, Merck wagers on strength of lung drug’s patents
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
An Opioid Defendant Sought Records From 1,000+ Cities and Counties. So Far, It's Sued Five of Them.
OptumRx, a pharmacy benefit manager accused in hundreds of lawsuits of contributing to the opioid crisis, sued five Kentucky ...